DE60017175D1 - Ciclesonidhaltige arzneizusammensetzung zur verabreichung auf die schleimhäute - Google Patents

Ciclesonidhaltige arzneizusammensetzung zur verabreichung auf die schleimhäute

Info

Publication number
DE60017175D1
DE60017175D1 DE60017175T DE60017175T DE60017175D1 DE 60017175 D1 DE60017175 D1 DE 60017175D1 DE 60017175 T DE60017175 T DE 60017175T DE 60017175 T DE60017175 T DE 60017175T DE 60017175 D1 DE60017175 D1 DE 60017175D1
Authority
DE
Germany
Prior art keywords
ciclesonic
mice
administration
drug composition
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60017175T
Other languages
English (en)
Other versions
DE60017175T2 (de
Inventor
Atsuhiro Nagano
Yoshihisa Nishibe
Kazuya Takanashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Altana Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17856327&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60017175(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma AG filed Critical Altana Pharma AG
Publication of DE60017175D1 publication Critical patent/DE60017175D1/de
Application granted granted Critical
Publication of DE60017175T2 publication Critical patent/DE60017175T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60017175T 1999-10-20 2000-10-20 Ciclesonidhaltige arzneizusammensetzung zur verabreichung auf die schleimhäute Expired - Lifetime DE60017175T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP29818599 1999-10-20
JP29818599 1999-10-20
PCT/JP2000/007350 WO2001028562A1 (en) 1999-10-20 2000-10-20 Ciclesonide contained pharmaceutical composition for application to mucosa

Publications (2)

Publication Number Publication Date
DE60017175D1 true DE60017175D1 (de) 2005-02-03
DE60017175T2 DE60017175T2 (de) 2005-12-29

Family

ID=17856327

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60017175T Expired - Lifetime DE60017175T2 (de) 1999-10-20 2000-10-20 Ciclesonidhaltige arzneizusammensetzung zur verabreichung auf die schleimhäute

Country Status (36)

Country Link
US (1) US6767901B1 (de)
EP (1) EP1225902B1 (de)
JP (1) JP4264211B2 (de)
KR (1) KR100722209B1 (de)
CN (2) CN1379674B (de)
AR (1) AR026072A1 (de)
AT (1) ATE285779T1 (de)
AU (1) AU781895B2 (de)
BG (1) BG65818B1 (de)
BR (1) BRPI0014878B8 (de)
CA (1) CA2388322C (de)
CO (1) CO5261494A1 (de)
CZ (1) CZ297779B6 (de)
DE (1) DE60017175T2 (de)
DK (1) DK1225902T3 (de)
EA (1) EA006015B1 (de)
ES (1) ES2234681T3 (de)
HK (2) HK1050858A1 (de)
HR (1) HRP20020346B1 (de)
HU (1) HU228893B1 (de)
IL (2) IL148691A0 (de)
ME (1) ME00567A (de)
MX (1) MXPA02003974A (de)
MY (1) MY136987A (de)
NO (1) NO327444B1 (de)
NZ (1) NZ518298A (de)
PE (1) PE20010712A1 (de)
PL (1) PL199702B1 (de)
PT (1) PT1225902E (de)
RS (1) RS50310B (de)
SI (1) SI1225902T1 (de)
SK (1) SK286196B6 (de)
TR (1) TR200200841T2 (de)
TW (1) TWI225788B (de)
WO (1) WO2001028562A1 (de)
ZA (1) ZA200203077B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
EP3513813A1 (de) * 2002-07-02 2019-07-24 Astrazeneca Ciclesonidhaltige sterile wässrige suspension
US7221586B2 (en) 2002-07-08 2007-05-22 Micron Technology, Inc. Memory utilizing oxide nanolaminates
AU2003261225A1 (en) * 2002-07-26 2004-02-16 Fmc Corporation Production of microcrystalline cellulose
SI1545548T1 (sl) * 2002-08-30 2010-11-30 Nycomed Gmbh Uporaba kombinacije ciklezonida in antihistaminikov za zdravljenje alergijskega rinitisa
WO2004052374A1 (en) * 2002-12-12 2004-06-24 Altana Pharma Ag Combination medicament
MY143936A (en) 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
WO2005025578A1 (en) * 2003-09-16 2005-03-24 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
WO2005102354A1 (en) * 2004-04-20 2005-11-03 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
CA2579007A1 (en) * 2004-09-10 2006-03-16 Altana Pharma Ag Ciclesonide and syk inhibitor combination and methods of use thereof
EP1645266A1 (de) * 2004-10-08 2006-04-12 Hisamitsu Medical Co., Ltd. Wässrige Suspension für Nasentropfen
WO2009114192A2 (en) * 2008-03-14 2009-09-17 Cephalon, Inc. Enhanced transmucosal composition and dosage form
WO2011135585A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63303931A (ja) * 1987-06-05 1988-12-12 Sumitomo Pharmaceut Co Ltd 経鼻投与用成長ホルモン放出活性物質製剤
GB9103824D0 (en) * 1991-02-23 1991-04-10 Fisons Ag Formulation
AU6392496A (en) 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
SE9704186D0 (sv) 1997-11-14 1997-11-14 Astra Ab New composition of matter
EP1050299A4 (de) 1998-01-22 2007-05-02 Santen Pharmaceutical Co Ltd Augentropfen aus fluorometholonsuspension
SE514128C2 (sv) 1998-03-17 2001-01-08 Pharmalink Ab Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa

Also Published As

Publication number Publication date
BG65818B1 (bg) 2010-01-29
CA2388322C (en) 2007-09-18
CO5261494A1 (es) 2003-03-31
HUP0203339A2 (hu) 2003-02-28
JP2003512329A (ja) 2003-04-02
KR20020059627A (ko) 2002-07-13
NZ518298A (en) 2003-11-28
NO20021898D0 (no) 2002-04-22
NO327444B1 (no) 2009-06-29
BRPI0014878B8 (pt) 2021-05-25
EA006015B1 (ru) 2005-08-25
CN1379674A (zh) 2002-11-13
IL148691A0 (en) 2002-09-12
CN1379674B (zh) 2014-10-29
CZ297779B6 (cs) 2007-03-28
RS50310B (sr) 2009-09-08
HRP20020346B1 (en) 2011-06-30
DK1225902T3 (da) 2005-05-02
TR200200841T2 (tr) 2002-07-22
EP1225902B1 (de) 2004-12-29
DE60017175T2 (de) 2005-12-29
ME00567B (me) 2011-12-20
MY136987A (en) 2008-12-31
AU7953100A (en) 2001-04-30
NO20021898L (no) 2002-04-22
EP1225902A1 (de) 2002-07-31
AR026072A1 (es) 2002-12-26
EA200200375A1 (ru) 2002-10-31
PL199702B1 (pl) 2008-10-31
TWI225788B (en) 2005-01-01
HK1149719A1 (en) 2011-10-14
HUP0203339A3 (en) 2004-07-28
BRPI0014878B1 (pt) 2015-08-11
ATE285779T1 (de) 2005-01-15
IL148691A (en) 2006-12-10
HU228893B1 (hu) 2013-06-28
ES2234681T3 (es) 2005-07-01
SK6922002A3 (en) 2002-09-10
BG106512A (bg) 2002-12-29
HK1050858A1 (zh) 2003-07-11
ZA200203077B (en) 2003-02-26
HRP20020346A2 (en) 2004-02-29
CN101869570B (zh) 2012-10-10
BR0014878A (pt) 2002-06-11
MXPA02003974A (es) 2003-09-25
CA2388322A1 (en) 2001-04-26
WO2001028562A1 (en) 2001-04-26
PE20010712A1 (es) 2001-07-12
YU28002A (sh) 2004-11-25
SK286196B6 (sk) 2008-05-06
ME00567A (en) 2011-12-20
CN101869570A (zh) 2010-10-27
PL356191A1 (en) 2004-06-14
SI1225902T1 (en) 2005-06-30
AU781895B2 (en) 2005-06-23
KR100722209B1 (ko) 2007-05-29
CZ20021238A3 (cs) 2002-07-17
JP4264211B2 (ja) 2009-05-13
US6767901B1 (en) 2004-07-27
PT1225902E (pt) 2005-05-31

Similar Documents

Publication Publication Date Title
NO20022970D0 (no) Hydrogel-drevet medikamentdoseringsform
NO20015175L (no) Farmasöytisk sammensetning
EE200000484A (et) Täiustused ravimi väljastusseadmetele
DK1204410T3 (da) Farmaceutisk doseringsform med flere komponenter
DE60014279D1 (de) Stiftförmige Medikamentenspritze
PT1242087E (pt) Composicoes farmaceuticas
DE60040876D1 (de) Medikamentenzuführeinrichtung
DE60033176D1 (de) Medikamentspender
NO20030627L (no) Hydrogel-drevet medikament doseringsform
NO20020086L (no) Smaksmaskerte farmasöytiske flytende formuleringer
DE60126321D1 (de) Gelsystem zur ocularen verabreichung von arzneimitteln
DE60017175D1 (de) Ciclesonidhaltige arzneizusammensetzung zur verabreichung auf die schleimhäute
FI4823U1 (fi) Muunnetulla tavalla vapauttava lääkeformulaatio
ATE264680T1 (de) Beta-carbolin arzneistoffprodukte
NO20015670L (no) Forbedrede farmasöytiske formuleringer
PT1173434E (pt) Novo produto farmaceutico
NO20022606L (no) Farmasöytiske kombinasjoner
PT1239832E (pt) Composicoes farmaceuticas
NO20014926D0 (no) Farmasöytiske forbindelser
ATE348599T1 (de) Pharmazeutische dronedaron-zusammensetzung für die parenterale verabreichung
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
FI4488U1 (fi) Farmaseuttinen koostumus
AR025867A1 (es) Formulacion portasdora farmaceutica
EE200100697A (et) Farmatseutiline kompleks
IT1316440B1 (it) Cannula erogatrice di unguenti medicinali.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NYCOMED GMBH, 78467 KONSTANZ, DE